CLINICAL_TRIALS
trial_result
· 2016-03-07
Clinical Trial Update: AGN-229666 Ophthalmic Solution in Japanese Patients With Allergic Conjunctivitis [Phase 3]
Summary
Phase 3 clinical trial update for AGN-229666 ophthalmic solution in Japanese patients with allergic conjunctivitis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Allergan | Conditions: Conjunctivitis, Allergic | Phase 3 | Status: COMPLETED | Results posted: 2016-03-07